Leptospirosis: Aspects of innate immunity, immunopathogenesis and immune evasion from the complement system

Scandinavian Journal of Immunology

Volumn 73, Issue 5, 2011, Pages 408-419

  Fraga, T R ^a   Barbosa, A S ^b   Isaac, L ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO BUTANTAN   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BACTERIUM LIPOPOLYSACCHARIDE; CATHELICIDIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CD209 ANTIGEN; DEFENSIN; HLA DQ ANTIGEN; LEPTOSPIRAL IMMUNOGLOBULIN LIKE PROTEIN; LEPTOSPIROSIS VACCINE; O ANTIGEN; PATHOGEN RECOGNITION RECEPTOR; PATTERN RECOGNITION RECEPTOR; PENTRAXIN 3; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; AUTOIMMUNE DISEASE; BACTERIAL COLONIZATION; BACTERIAL GENOME; BACTERIAL MEMBRANE; BACTERIAL OUTER MEMBRANE; BACTERICIDAL ACTIVITY; BORRELIA BURGDORFERI; CELL INVASION; CLINICAL FEATURE; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT CLASSICAL PATHWAY; COMPLEMENT LECTIN PATHWAY; COMPLEMENT SYSTEM; EXPERIMENTAL MODEL; EXTRACELLULAR MATRIX; GENE SEQUENCE; GUILLAIN BARRE SYNDROME; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOPATHOGENESIS; INNATE IMMUNITY; KIDNEY DISEASE; LEPTOSPIRA; LEPTOSPIRA INTERROGANS; LEPTOSPIROSIS; LUNG HEMORRHAGE; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; SEROTYPE; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; UVEITIS;

ANIMALS; COMPLEMENT SYSTEM PROTEINS; DISEASE MODELS, ANIMAL; HUMANS; IMMUNE EVASION; IMMUNITY, INNATE; LEPTOSPIRA; LEPTOSPIROSIS; ZOONOSES;

EID: 79953039020     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2010.02505.x     Document Type: Review

References (106)

1. Levett PN. Leptospirosis. Clin Microbiol Rev 2001;14:296-326.
2. World Health Organization. Leptospirosis worldwide. Wkly Epidemiol Rec 1999;74:237-42.
3. Reis RB, Ribeiro GS, Felzemburgh RD et al. Impact of environment and social gradient on Leptospira infection in urban slums. PLoS Negl Trop Dis 2008;2:e228.
4. Faine S, Adler B, Bolin C, Perolat P. Leptospira and Leptospirosis. Melbourne: MedScience, 1999.
5. Nalam K, Ahmed A, Devi SM et al. Genetic affinities within a large global collection of pathogenic Leptospira: implications for strain identification and molecular epidemiology. PLoS One 2010;5:e12637.
6. Haake DA. Spirochaetal lipoproteins and pathogenesis. Microbiology 2000;146:1491-504.
7. Cullen PA, Haake DA, Adler B. Outer membrane proteins of pathogenic spirochetes. FEMS Microbiol Rev 2004;28:291-318.
8. Que-Gewirth NL, Ribeiro AA, Kalb SR et al. A methylated phosphate group and four amide-linked acyl chains in leptospira interrogans lipid A. The membrane anchor of an unusual lipopolysaccharide that activates TLR2. J Biol Chem 2004;279:25420-9.
9. Ristow P, Bourhy P, da Cruz McBride FW et al. The OmpA-like protein Loa22 is essential for leptospiral virulence. PLoS Pathog 2007;3:e97.
10. Murray GL, Ellis KM, Lo M, Adler B. Leptospira interrogans requires a functional heme oxygenase to scavenge iron from hemoglobin. Microbes Infect 2008;10:791-7.
11. Liao S, Sun A, Ojcius DM, Wu S, Zhao J, Yan J. Inactivation of the fliY gene encoding a flagellar motor switch protein attenuates mobility and virulence of Leptospira interrogans strain Lai. BMC Microbiol 2009;9:253.
12. Murray GL, Srikram A, Henry R, Hartskeerl RA, Sermswan RW, Adler B. Mutations affecting Leptospira interrogans lipopolysaccharide attenuate virulence. Mol Microbiol 2010;78:701-9.
13. Bharti AR, Nally JE, Ricaldi JN et al. Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis 2003;3:757-71.
14. Gouveia EL, Metcalfe J, de Carvalho AL et al. Leptospirosis-associated severe pulmonary hemorrhagic syndrome, Salvador, Brazil. Emerg Infect Dis 2008;14:505-8.
15. Marotto PC, Nascimento CM, Eluf-Neto J et al. Acute lung injury in leptospirosis: clinical and laboratory features, outcome, and factors associated with mortality. Clin Infect Dis 1999;29:1561-3.
16. Panaphut T, Domrongkitchaiporn S, Thinkamrop B. Prognostic factors of death in leptospirosis: a prospective cohort study in Khon Kaen, Thailand. Int J Infect Dis 2002;6:52-9.
17. Spichler AS, Vilaça PJ, Athanazio DA et al. Predictors of lethality in severe leptospirosis in urban Brazil. Am J Trop Med Hyg 2008;79:911-4.
18. Ganoza CA, Matthias MA, Saito M, Cespedes M, Gotuzzo E, Vinetz JM. Asymptomatic renal colonization of humans in the peruvian Amazon by Leptospira. PLoS Negl Trop Dis 2010;4:e612.
19. Barbosa AS, Abreu PA, Neves FO et al. A newly identified leptospiral adhesin mediates attachment to laminin. Infect Immun 2006;74:6356-64.
20. Choy HA, Kelley MM, Chen TL, Møller AK, Matsunaga J, Haake DA. Physiological osmotic induction of Leptospira interrogans adhesion: LigA and LigB bind extracellular matrix proteins and fibrinogen. Infect Immun 2007;75:2441-50.
21. Lin YP, Lee DW, McDonough SP, Nicholson LK, Sharma Y, Chang YF. Repeated domains of leptospira immunoglobulin-like proteins interact with elastin and tropoelastin. J Biol Chem 2009;284:19380-91.
22. Breiner DD, Fahey M, Salvador R, Novakova J, Coburn J. Leptospira interrogans binds to human cell surface receptors including proteoglycans. Infect Immun 2009;77:5528-36.
23. Thomas DD, Higbie LM. In vitro association of leptospires with host cells. Infect Immun 1990;58:581-5.
24. Liu Y, Zheng W, Li L, Mao Y, Yan J. Pathogenesis of leptospirosis: interaction of Leptospira interrogans with in vitro cultured mammalian cells. Med Microbiol Immunol 2007;196:233-9.
25. Barocchi MA, Ko AI, Reis MG, McDonald KL, Riley LW. Rapid translocation of polarized MDCK cell monolayers by Leptospira interrogans, an invasive but nonintracellular pathogen. Infect Immun 2002;70:6926-32.
26. Faisal SM, Yan W, McDonough SP, Chang YF. Leptospira immunoglobulin-like protein A variable region (LigAvar) incorporated in liposomes and PLGA microspheres produces a robust immune response correlating to protective immunity. Vaccine 2009;27:378-87.
27. Meri T, Murgia R, Stefanel P, Meri S, Cinco M. Regulation of complement activation at the C3-level by serum resistant leptospires. Microb Pathog 2005;39:139-47.
28. Barbosa AS, Abreu PA, Vasconcellos SA et al. Immune evasion of leptospira species by acquisition of human complement regulator C4BP. Infect Immun 2009;77:1137-43.
29. Jost BH, Adler B, Vinh T, Faine S. A monoclonal antibody reacting with a determinant on leptospiral lipopolysaccharide protects guinea pigs against leptospirosis. J Med Microbiol 1986;22:269-75.
30. Wang B, Sullivan JA, Sullivan GW, Mandell GL. Role of specific antibody in interaction of leptospires with human monocytes and monocyte-derived macrophages. Infect Immun 1984;46:809-13.
31. Wang B, Sullivan J, Sullivan GW, Mandell GL. Interaction of leptospires with human polymorphonuclear neutrophils. Infect Immun 1984;44:459-64.
32. Banfi E, Cinco M, Bellini M, Soranzo MR. The role of antibodies and serum complement in the interaction between macrophages and leptospires. J Gen Microbiol 1982;128:813-6.
33. Cinco M, Cini B, Perticarari S, Presani G. Leptospira interrogans binds to the CR3 receptor on mammalian cells. Microb Pathog 2002;33:299-305.
34. Malkin K. Enhancement of Leptospira hardjo agglutination titers in sheep and goat serum by heat inactivation. Can J Comp Med 1984;48:208-10.
35. Naiman BM, Alt D, Bolin CA, Zuerner R, Baldwin CL. Protective killed Leptospira borgpetersenii vaccine induces potent Th1 immunity comprising responses by CD4 and gammadelta T lymphocytes. Infect Immun 2001;69:7550-8.
36. Naiman BM, Blumerman S, Alt D et al. Evaluation of type 1 immune response in naïve and vaccinated animals following challenge with Leptospira borgpetersenii serovar Hardjo: involvement of WC1(+) gammadelta and CD4 T cells. Infect Immun 2002;70:6147-57.
37. Tuero I, Vinetz JM, Klimpel GR. Lack of demonstrable memory T cell responses in humans who have spontaneously recovered from leptospirosis in the Peruvian Amazon. J Infect Dis 2010;201:420-7.
38. Klimpel GR, Matthias MA, Vinetz JM. Leptospira interrogans activation of human peripheral blood mononuclear cells: preferential expansion of TCR gamma delta+ T cells vs TCR alpha beta+ T cells. J Immunol 2003;171:1447-55.
39. Li S, Ojcius DM, Liao S et al. Replication or death: distinct fates of pathogenic Leptospira strain Lai within macrophages of human or mouse origin. Innate Immun 2010;16:80-92.
40. Guo YJ, Wang KY, Sun SH. Identification of an HLA-A*0201-restricted CD8(+) T-cell epitope encoded within Leptospiral immunoglobulin-like protein A. Microbes Infect 2010;12:364-73.
41. Mogensen TH. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev 2009;22:240-73.
42. Miller SI, Ernst RK, Bader MW. LPS, TLR4 and infectious disease diversity. Nat Rev Microbiol 2005;3:36-46.
43. Werts C, Tapping RI, Mathison JC et al. Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism. Nat Immunol 2001;2:346-52.
44. Nahori MA, Fournié-Amazouz E, Que-Gewirth NS et al. Differential TLR recognition of leptospiral lipid A and lipopolysaccharide in murine and human cells. J Immunol 2005;175:6022-31.
45. Chassin C, Picardeau M, Goujon JM et al. TLR4- and TLR2-mediated B cell responses control the clearance of the bacterial pathogen, Leptospira interrogans. J Immunol 2009;183:2669-77.
46. Behera AK, Hildebrand E, Uematsu S, Akira S, Coburn J, Hu LT. Identification of a TLR-independent pathway for Borrelia burgdorferi-induced expression of matrix metalloproteinases and inflammatory mediators through binding to integrin alpha 3 beta 1. J Immunol 2006;177:657-64.
47. Geijtenbeek TB, van Kooyk Y. Pathogens target DC-SIGN to influence their fate DC-SIGN functions as a pathogen receptor with broad specificity. APMIS 2003;111:698-714.
48. Gaudart N, Ekpo P, Pattanapanyasat K, van Kooyk Y, Engering A. Leptospira interrogans is recognized through DC-SIGN and induces maturation and cytokine production by human dendritic cells. FEMS Immunol Med Microbiol 2008;53:359-67.
49. van Kooyk Y, Geijtenbeek TB. DC-SIGN: escape mechanism for pathogens. Nat Rev Immunol 2003;3:697-709.
50. Murgia R, Garcia R, Cinco M. Leptospires are killed in vitro by both oxygen-dependent and -independent reactions. Infect Immun 2002;70:7172-5.
51. Picardeau M, Bulach DM, Bouchier C et al. Genome sequence of the saprophyte Leptospira biflexa provides insights into the evolution of Leptospira and the pathogenesis of leptospirosis. PLoS One 2008;3:e1607.
52. Nascimento AL, Verjovski-Almeida S, Van Sluys MA et al. Genome features of Leptospira interrogans serovar Copenhageni. Braz J Med Biol Res 2004;37:459-77.
53. Guaní-Guerra E, Santos-Mendoza T, Lugo-Reyes SO, Terán LM. Antimicrobial peptides: general overview and clinical implications in human health and disease. Clin Immunol 2010;135:1-11.
54. Sambri V, Marangoni A, Giacani L et al. Comparative in vitro activity of five cathelicidin-derived synthetic peptides against Leptospira, Borrelia and Treponema pallidum. J Antimicrob Chemother 2002;50:895-902.
55. Wu Q, Xu L, Wang X, Li S, Wang B. Investigation of microbicidal activity of neutrophil defensins against leptospires. Hua Xi Yi Ke Da Xue Xue Bao 1992;23:126-9.
56. Tajiki H, Salomão R. Association of plasma levels of tumor necrosis factor alpha with severity of disease and mortality among patients with leptospirosis. Clin Infect Dis 1996;23:1177-8.
57. Wagenaar JF, Gasem MH, Goris MG et al. Soluble ST2 levels are associated with bleeding in patients with severe Leptospirosis. PLoS Negl Trop Dis 2009;3:e453.
58. Bottazzi B, Doni A, Garlanda C, Mantovani A. An integrated view of humoral innate immunity: pentraxins as a paradigm. Annu Rev Immunol 2010;28:157-83.
59. Wagenaar JF, Goris MG, Gasem MH, et al. Long pentraxin PTX3 is associated with mortality and disease severity in severe Leptospirosis. J Infect 2009;58:425-32.
60. Lingappa J, Kuffner T, Tappero J et al. HLA-DQ6 and ingestion of contaminated water: possible gene-environment interaction in an outbreak of Leptospirosis. Genes Immun 2004;5:197-202.
61. Fialho RN, Martins L, Pinheiro JP et al. Role of human leukocyte antigen, killer-cell immunoglobulin-like receptors, and cytokine gene polymorphisms in leptospirosis. Hum Immunol 2009;70:915-20.
62. Yang CW. Leptospirosis renal disease: understanding the initiation by Toll-like receptors. Kidney Int 2007;72:918-25.
63. Anders HJ, Banas B, Schlöndorff D. Signaling danger: toll-like receptors and their potential roles in kidney disease. J Am Soc Nephrol 2004;15:854-67.
64. Yang CW, Hung CC, Wu MS et al. Toll-like receptor 2 mediates early inflammation by leptospiral outer membrane proteins in proximal tubule cells. Kidney Int 2006;69:815-22.
65. Hung CC, Chang CT, Tian YC et al. Leptospiral membrane proteins stimulate pro-inflammatory chemokines secretion by renal tubule epithelial cells through toll-like receptor 2 and p38 mitogen activated protein kinase. Nephrol Dial Transplant 2006;21:898-910.
66. Tian YC, Chen YC, Hung CC et al. Leptospiral outer membrane protein induces extracellular matrix accumulation through a TGF-beta1/Smad-dependent pathway. J Am Soc Nephrol 2006;17:2792-8.
67. Miller NG, Allen JE, Wilson RB. The pathogenesis of hemorrhage in the lung of the hamster during acute leptospirosis. Med Microbiol Immunol 1974;160:269-78.
68. Ren SX, Fu G, Jiang XG et al. Unique physiological and pathogenic features of Leptospira interrogans revealed by whole-genome sequencing. Nature 2003;422:888-93.
69. Bulach DM, Zuerner RL, Wilson P et al. Genome reduction in Leptospira borgpetersenii reflects limited transmission potential. Proc Natl Acad Sci USA 2006;103:14560-5.
70. Nally JE, Chantranuwat C, Wu XY et al. Alveolar septal deposition of immunoglobulin and complement parallels pulmonary hemorrhage in a guinea pig model of severe pulmonary leptospirosis. Am J Pathol 2004;164:1115-27.
71. Croda J, Neto AN, Brasil RA, Pagliari C, Nicodemo AC, Duarte MI. Leptospirosis pulmonary haemorrhage syndrome is associated with linear deposition of immunoglobulin and complement on the alveolar surface. Clin Microbiol Infect 2010;16:593-9.
72. Craig SB, Graham GC, Burns MA et al. Leptospirosis and Goodpasture's syndrome: testing the aetiological hypothesis. Ann Trop Med Parasitol 2009;103:647-51.
73. Verma A, Rathinam SR, Priya CG, Muthukkaruppan VR, Stevenson B, Timoney JF. LruA and LruB antibodies in sera of humans with leptospiral uveitis. Clin Vaccine Immunol 2008;15:1019-23.
74. Priya CG, Rathinam SR, Muthukkaruppan V. Evidence for endotoxin as a causative factor for leptospiral uveitis in humans. Invest Ophthalmol Vis Sci 2008;49:5419-24.
75. Verma A, Kumar P, Babb K, Timoney JF, Stevenson B. Cross-reactivity of antibodies against leptospiral recurrent uveitis-associated proteins A and B (LruA and LruB) with eye proteins. PLoS Negl Trop Dis 2010;4:e778.
76. Bal AM, Bharadwaj RS, Gita N, Joshi SA, Thakare JP. Guillain-Barre syndrome in a pediatric patient following infection due to Leptospira. Jpn J Infect Dis 2003;56:29-31.
77. Rugman FP, Pinn G, Palmer MF, Waite M, Hay CR. Anticardiolipin antibodies in leptospirosis. J Clin Pathol 1991;44:517-9.
78. Johnson RC, Muschel LH. Antileptospiral activity of normal serum. J Bacteriol 1965;89:1625-6.
79. Johnson RC, Harris VG. Antileptospiral activity of serum. II. Leptospiral virulence factor. J Bacteriol 1967;93:513-9.
80. Charon NW, Johnson RC, Muschel LH. Antileptospiral activity in lower-vertebrate sera. Infect Immun 1975;12:1386-91.
81. Zipfel PF, Würzner R, Skerka C. Complement evasion of pathogens: common strategies are shared by diverse organisms. Mol Immunol 2007;44:3850-7.
82. Verma A, Hellwage J, Artiushin S et al. LfhA, a novel factor H-binding protein of Leptospira interrogans. Infect Immun 2006;74:2659-66.
83. Stevenson B, Choy HA, Pinne M et al. Leptospira interrogans endostatin-like outer membrane proteins bind host fibronectin, laminin and regulators of complement. PLoS One 2007;2:e1188.
84. Verma A, Brissette CA, Bowman AA, Shah ST, Zipfel PF, Stevenson B. Leptospiral endostatin-like protein A is a bacterial cell surface receptor for human plasminogen. Infect Immun 2010;78:2053-9.
85. Barbosa AS, Monaris D, Silva LB et al. Functional characterization of LcpA, a surface-exposed protein of Leptospira spp. that binds the human complement regulator C4BP. Infect Immun 2010;78:3207-16.
86. Cinco M, Perticarari S, Presani G, Dobrina A, Liut F. Biological activity of a peptidoglycan extracted from Leptospira interrogans: in vitro studies. J Gen Microbiol 1993;139:2959-64.
87. Monahan AM, Callanan JJ, Nally JE. Review paper: host-pathogen interactions in the kidney during chronic leptospirosis. Vet Pathol 2009;46:792-9.
88. Nally JE, Chow E, Fishbein MC, Blanco DR, Lovett MA. Changes in lipopolysaccharide O antigen distinguish acute versus chronic Leptospira interrogans infections. Infect Immun 2005;73:3251-60.
89. Clay CD, Soni S, Gunn JS, Schlesinger LS. Evasion of complement-mediated lysis and complement C3 deposition are regulated by Francisella tularensis lipopolysaccharide O antigen. J Immunol 2008;181:5568-78.
90. Monahan AM, Callanan JJ, Nally JE. Proteomic analysis of Leptospira interrogans shed in urine of chronically infected hosts. Infect Immun 2008;76:4952-8.
91. Ristow P, Bourhy P, Kerneis S et al. Biofilm formation by saprophytic and pathogenic leptospires. Microbiology 2008;154:1309-17.
92. Kharazmi A. Mechanisms involved in the evasion of the host defence by Pseudomonas aeruginosa. Immunol Lett 1991;30:201-5.
93. Haake DA. Hamster model of leptospirosis. Curr Protoc Microbiol 2006;Chapter 12(Unit 12E.2).
94. Nally JE, Fishbein MC, Blanco DR, Lovett MA. Lethal infection of C3H/HeJ and C3H/SCID mice with an isolate of Leptospira interrogans serovar copenhageni. Infect Immun 2005;73:7014-7.
95. Pereira MM, Da Silva JJ, Pinto MA et al. Experimental leptospirosis in marmoset monkeys (Callithrix jacchus): a new model for studies of severe pulmonary leptospirosis. Am J Trop Med Hyg 2005;72:13-20.
96. Silva EF, Santos CS, Athanazio DA et al. Characterization of virulence of Leptospira isolates in a hamster model. Vaccine 2008;26:3892-6.
97. Silva EF, Medeiros MA, McBride AJ et al. The terminal portion of leptospiral immunoglobulin-like protein LigA confers protective immunity against lethal infection in the hamster model of leptospirosis. Vaccine 2007;25:6277-86.
98. Vernel-Pauillac F, Merien F. Proinflammatory and immunomodulatory cytokine mRNA time course profiles in hamsters infected with a virulent variant of Leptospira interrogans. Infect Immun 2006;74:4172-9.
99. Vernel-Pauillac F, Goarant C. Differential cytokine gene expression according to outcome in a hamster model of leptospirosis. PLoS Negl Trop Dis 2010;4:e582.
100. Koizumi N, Watanabe H. Leptospiral immunoglobulin-like proteins elicit protective immunity. Vaccine 2004;12:1545-52.
101. Santos CS, Macedo JO, Bandeira M et al. Different outcomes of experimental leptospiral infection in mouse strains with distinct genotypes. J Med Microbiol 2010;59:1101-6.
102. da Silva JB, Ramos TM, de Franco M et al. Chemokines expression during Leptospira interrogans serovar Copenhageni infection in resistant BALB/c and susceptible C3H/HeJ mice. Microb Pathog 2009;47:87-93.
103. Athanazio DA, Silva EF, Santos CS et al. Rattus norvegicus as a model for persistent renal colonization by pathogenic Leptospira interrogans. Acta Trop 2008;105:176-80.
104. Martínez R, Pérez A, Quiñones Mdel C et al. Efficacy and safety of a vaccine against human leptospirosis in Cuba. Rev Panam Salud Publica 2004;15:249-55.
105. Yan Y, Chen Y, Liou W et al. An evaluation of the serological and epidemiological effects of the outer envelope vaccine to leptospira. J Chin Med Assoc 2003;66:224-30.
106. Matsunaga J, Barocchi MA, Croda J et al. Pathogenic Leptospira species express surface-exposed proteins belonging to the bacterial immunoglobulin superfamily. Mol Microbiol 2003;49:929-45.